Evidence map›Paper›PMID 40071020›Full record

ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2025

Different Modalities in the Management of Post-COVID-19 Olfactory Dysfunction.

Ahmed Shehata El Sayed Saleh, Ayman Abdelaal Mohamady, Mostafa Gomaa Sobhey, Eslam Farid Abu Shady

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ahmed Shehata El Sayed SalehOtorhinolaryngology Department, Faculty of Medicine, Benha University, Benha, Qalyubia Egypt.ORCID 0000-0001-8584-5106
Ayman Abdelaal MohamadyOtorhinolaryngology Department, Faculty of Medicine, Benha University, Benha, Qalyubia Egypt.
Mostafa Gomaa SobheyOtorhinolaryngology Department, Faculty of Medicine, Benha University, Benha, Qalyubia Egypt.
Eslam Farid Abu ShadyOtorhinolaryngology Department, Faculty of Medicine, Benha University, Benha, Qalyubia Egypt.ORCID 0000-0002-9161-3149

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 infection may lead to olfactory dysfunctions affecting patients' quality of life. Despite various ongoing studies, solid evidence supporting therapies, especially for COVID-19-related olfactory dysfunction, remains scarce. To assess nasal steroid, nasal vitamin A, and intranasal theophylline as treatment options for post-COVID-19 olfactory dysfunction. This is a multi-center retrospective case-controlled study of 120 cases with post-COVID-19 olfactory dysfunction (hyposmia or anosmia) at Benha University Hospitals, Egypt, and Dallah Hospital, Riyadh City, Kingdom of Saudi Arabia (KSA) between January 2020 and December 2022. 43.3% males and 56.6% females with median age was 38.5 years. Nasal steroid, nasal vitamin A, and intranasal theophylline had a significantly reduced time for complete smell recovery (25.7 ± 9.20 days, 24.8 ± 6.67 days. 23.5 ± 7.13 days Respectively) in comparison to the control group (olfactory training alone) (28.97 ± 4.29 days) (

Indexed as

AnosmiaCOVID-19OlfactionOlfactory DysfunctionSARS-CoV-2

Identifiers

PMID40071020
PMCPMC11890883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.